Abbott's FreeStyle Libre® 2 Now Reimbursed for Children and Adults Living with Diabetes in Alberta [Globe and Mail, The (Toronto, Canada)]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Globe and Mail, The
Starting December 16, 2024 Alberta residents living with diabetes can access provincial reimbursement of the FreeStyle Libre 2 system if they are 18 or older and are being treated with insulin pump therapy, both basal and bolus insulin, or premixed insulin. People under the age of 18 can access the FreeStyle Libre 2 flash glucose monitoring system* if they use any type of insulin. "This is important news for Albertans living with diabetes," said Jeff Winterstein , M.D., an Edmonton -based internist who specializes in diabetes. "Providing access to advanced glucose monitoring will empower people living with diabetes to self-manage their condition and helps me, as a healthcare provider, make informed treatment decisions that ultimately lead to better health outcomes." Abbott's FreeStyle Libre 2 system represents a significant advancement in diabetes management. The system continues to be the market leader in Alberta and is Canada's leading sensor-based glucose monitoring system . I
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott (ABT) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- South Korea Baby Food Market Assessment and Forecasts to 2029: Deceleration in South Korea's Birth Rates Influences Baby Food Sector Dynamics [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- 2 Excellent Dividend Stocks to Buy on the Dip [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories' (NYSE:ABT) investors will be pleased with their respectable 43% return over the last five years [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/16/24 - Beat
ABT
Sec Filings
- 11/15/24 - Form 8-K
- 11/4/24 - Form 144
- 10/31/24 - Form 10-Q
- ABT's page on the SEC website